Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07018726 · ClinicalTrials.gov registry record · NA
Addressing Emotional Distress in Dyads of Persons With a Young Onset Dementia (YOD) and Their Care-partners
A NA study of Young Onset Dementia, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 388
- Enrollment target
- 1
- Study location
NCT07018726: Recruiting NA study of Young Onset Dementia, sponsored by Massachusetts General Hospital.
NCT07018726 is a NA study of Young Onset Dementia that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 388 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07018726, a NA study of Young Onset Dementia, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 388 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the present investigation is to test the efficacy of a virtual, brief (6 sessions) dyadic (patient and care-partner together) intervention to prevent chronic emotional distress in dyads where one person is diagnosed with Young Onset Dementia (YOD). Through this study, we seek to address the unmet need of preventing chronic emotional distress in YOD dyads through a feasible, acceptable and credible program, and ideally enhance resiliency and improve wellbeing and quality of life in both members of the dyad.
Primary Outcome
Hospital Depression and Anxiety Scale total score (HADS); 0-21 for each subscale (anxiety and depression), higher scores indicate greater anxiety or depression
Conditions Studied
Interventions
- BEHAVIORAL Resilient Together-YOD
- BEHAVIORAL Health Enhancement Program-YOD
Study Locations (1)
Massachusetts
- Massachusetts General Hospital (MGH) - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 388 participants |
| Start Date | 2026-01-28 |
| Est. Completion | 2031-01-01 |
| Phase | NA |
What NCT07018726 shows while recruiting
NCT07018726 is an interventional study that assigns participants to a tested intervention. The registered 388 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Young Onset Dementia appearing as the primary indexed condition, and to 2 interventions - of which Resilient Together-YOD is the first listed.
NCT07018726 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07018726 about?
NCT07018726 is a clinical study titled "Addressing Emotional Distress in Dyads of Persons With a Young Onset Dementia (YOD) and Their Care-partners". The purpose of the present investigation is to test the efficacy of a virtual, brief (6 sessions) dyadic (patient and care-partner together) intervention to prevent chronic emotional distress in dyads where one person is diagnosed with Young Onset Dementia (YOD). Through this study, we seek to addre...
What is the current status of trial NCT07018726?
This trial is currently recruiting. It is a NA study. The enrollment target is 388 participants. The study started on 2026-01-28. Estimated completion is 2031-01-01.
What conditions does trial NCT07018726 study?
This clinical trial studies the following conditions: Young Onset Dementia.
What interventions are being tested in trial NCT07018726?
The interventions under investigation include: Resilient Together-YOD (BEHAVIORAL), Health Enhancement Program-YOD (BEHAVIORAL).
Who is sponsoring clinical trial NCT07018726?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07018726 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07018726's enrollment target sits among peer trials
388 270th of 2000 higher than 1,731 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04092010 · 388 participants · NA
Improving Preschool Outcomes by Addressing Maternal Depression in Head Start
- NCT05157880 · 388 participants · NA
Building Resiliency in Dyads of Patients With an ANI Admitted to the Neuro-ICU and Their Informal Caregivers
- NCT05748613 · 388 participants · NA
Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's
- NCT06374277 · 388 participants · NA
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI